nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)
|
Banzato, A. |
|
2011 |
128 |
6 |
p. 583-586 4 p. |
artikel |
2 |
Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays
|
Devreese, Katrien M.J. |
|
2011 |
128 |
6 |
p. 598-600 3 p. |
artikel |
3 |
Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: An updated meta-analysis
|
Liu, Yan Ping |
|
2011 |
128 |
6 |
p. 593-594 2 p. |
artikel |
4 |
B and T lymphocytes in acquired Thrombotic Thrombocytopenic Purpura during disease remission
|
Mariani, Mariagabriella |
|
2011 |
128 |
6 |
p. 590-592 3 p. |
artikel |
5 |
Combination oral antiplatelet therapy may increase the risk of hemorrhagic complications in patients with acute ischemic stroke caused by large artery disease
|
Itabashi, Ryo |
|
2011 |
128 |
6 |
p. 541-546 6 p. |
artikel |
6 |
Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas
|
Harris, Leanne F. |
|
2011 |
128 |
6 |
p. e125-e129 nvt p. |
artikel |
7 |
Comparison of the anticoagulant response of a novel fluorogenic anti-FXa assay with two commercial anti-FXa chromogenic assays
|
Harris, Leanne F. |
|
2011 |
128 |
6 |
p. e166-e170 nvt p. |
artikel |
8 |
Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention
|
Ono, Takamichi |
|
2011 |
128 |
6 |
p. e130-e136 nvt p. |
artikel |
9 |
Early stroke-related DVT is more than just DVT diagnosed early after stroke onset
|
Bembenek, Jan Paweł |
|
2011 |
128 |
6 |
p. 587-589 3 p. |
artikel |
10 |
Echocardiographic evaluation for pulmonary hypertension after recurrent pulmonary embolism
|
Berghaus, Thomas M. |
|
2011 |
128 |
6 |
p. e144-e147 nvt p. |
artikel |
11 |
Editorial Board
|
|
|
2011 |
128 |
6 |
p. IFC- 1 p. |
artikel |
12 |
Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina
|
Kajiwara, Ichiro |
|
2011 |
128 |
6 |
p. 547-551 5 p. |
artikel |
13 |
Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome
|
Persijn, Lies |
|
2011 |
128 |
6 |
p. 565-569 5 p. |
artikel |
14 |
Factor IX-R338L (Factor IX Padua) screening in a Dutch population of sibpairs with early onset venous thromboembolism
|
Koenderman, Jorine S. |
|
2011 |
128 |
6 |
p. 603- 1 p. |
artikel |
15 |
Factor VIIa-AT complex plasma levels and arterial thrombosis
|
Simioni, Paolo |
|
2011 |
128 |
6 |
p. 507- 1 p. |
artikel |
16 |
Increased expression of TF in BMP-7-treated human mononuclear cells depends on activation of select MAPK signaling pathways
|
Sovershaev, M.A. |
|
2011 |
128 |
6 |
p. e154-e159 nvt p. |
artikel |
17 |
In vitro recovery of Th1/Th2 balance in PBMCs from patients with immune thrombocytopenia through the actions of IL-18BPa/Fc
|
Shan, Ning-ning |
|
2011 |
128 |
6 |
p. e119-e124 nvt p. |
artikel |
18 |
Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?
|
Montoro-García, Silvia |
|
2011 |
128 |
6 |
p. 601-602 2 p. |
artikel |
19 |
MP's and VTE's: Fact or fiction
|
Owens III, A. Phillip |
|
2011 |
128 |
6 |
p. 505-506 2 p. |
artikel |
20 |
Obesity and pulmonary embolism: The mounting evidence of risk and the mortality paradox
|
Stein, Paul D. |
|
2011 |
128 |
6 |
p. 518-523 6 p. |
artikel |
21 |
Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: Involvement of mononuclear cell-platelet interaction
|
Hayashi, Mutsuharu |
|
2011 |
128 |
6 |
p. e113-e118 nvt p. |
artikel |
22 |
Predictive blood coagulation markers for early diagnosis of venous thromboembolism after total knee joint replacement
|
Watanabe, Hideaki |
|
2011 |
128 |
6 |
p. e137-e143 nvt p. |
artikel |
23 |
PROTHROMBINEX®-VF (PTX-VF) usage for reversal of coagulopathy: Prospective evaluation of thrombogenic risk
|
Bobbitt, Louise |
|
2011 |
128 |
6 |
p. 577-582 6 p. |
artikel |
24 |
Psychological impact of thrombophilia testing in asymptomatic family members
|
Louzada, Martha L. |
|
2011 |
128 |
6 |
p. 530-535 6 p. |
artikel |
25 |
Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma
|
Gray, Laura D. |
|
2011 |
128 |
6 |
p. 570-576 7 p. |
artikel |
26 |
Role of platelet glycoprotein receptor IIIa PIA2 and traditional risk factors in the etiology of coronary thrombosis
|
Dayakar, Seetha |
|
2011 |
128 |
6 |
p. 595-597 3 p. |
artikel |
27 |
Salvianolic acid B suppresses IFN-γ-induced JAK/STAT1 activation in endothelial cells
|
Chen, Shih Chung |
|
2011 |
128 |
6 |
p. 560-564 5 p. |
artikel |
28 |
Stable expression of native Coagulation factor VIII using the 2A self-processing sequence and furin cleavage site
|
He, Bangshun |
|
2011 |
128 |
6 |
p. e148-e153 nvt p. |
artikel |
29 |
THE NATF CORNER
|
Sasahara, Arthur A. |
|
2011 |
128 |
6 |
p. 516-517 2 p. |
artikel |
30 |
The occurrence of antibodies to heparin-platelet factor 4 in cardiac and thoracic surgical patients receiving desirudin or heparin for postoperative venous thrombosis prophylaxis
|
Avidan, Michael S. |
|
2011 |
128 |
6 |
p. 524-529 6 p. |
artikel |
31 |
The risk of occurrence of venous thrombosis: focus on protein Z
|
Bafunno, Valeria |
|
2011 |
128 |
6 |
p. 508-515 8 p. |
artikel |
32 |
Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice
|
Ding, Renyu |
|
2011 |
128 |
6 |
p. e160-e165 nvt p. |
artikel |
33 |
Ultrastructural analysis of thrombin-induced interaction between human platelets and liposomes carrying fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute
|
Suzuki, Hidenori |
|
2011 |
128 |
6 |
p. 552-559 8 p. |
artikel |
34 |
Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism
|
Lewis, Deborah A. |
|
2011 |
128 |
6 |
p. 536-540 5 p. |
artikel |